Q4 2017 Holdings
Filed 2018-02-12 | 137 holdings | $72.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc(BIIB) | COM | 09062X103 | $23.6M | 74,200 | 32.7% |
| Cellectis S A(CLLS) | SPONSORED ADS | 15117K103 | $9.9M | 339,367 | 13.7% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $7.1M | 1,044,131 | 9.8% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $5.2M | 129,474 | 7.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $5.1M | 170,000 | 7.1% |
| Charter Communications Inc N(CHTR) | CL A | 16119P108 | $3.9M | 11,629 | 5.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $3.4M | 160,000 | 4.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $3.1M | 35,000 | 4.3% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.3M | 221,430 | 3.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $2.3M | 345,000 | 3.1% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $2.3M | 576,825 | 3.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.7M | 210,000 | 2.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.7M | 301,000 | 2.3% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $165.5K | 1,950,000 | 0.2% |
| Ishares TR(IBB)Put | NASDAQ BIOTECH | 464287556 | $53.4K | 500,000 | 0.1% |
| Celgene Corp(CELG) | COM | 151020104 | $32.2K | 309,000 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $32.0K | 756,449 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $23.9K | 425,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $21.4K | 384,997 | 0.0% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $16.0K | 450,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $15.8K | 1,100,000 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $14.4K | 120,000 | 0.0% |
| Pfizer Inc(PFE) | COM | 717081103 | $14.1K | 390,000 | 0.0% |
| Cellcom Israel LTD(CEL) | SHS | M2196U109 | $14.0K | 1,359,744 | 0.0% |
| Shire PLC | SPONSORED ADR | 82481R106 | $13.4K | 86,500 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $12.9K | 85,823 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $10.7K | 158,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $10.2K | 210,000 | 0.0% |
| Nice LTD(NSY) | SPONSORED ADR | 653656108 | $9.9K | 107,870 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $9.8K | 60,000 | 0.0% |
| Ignyta Inc | COM | 451731103 | $9.2K | 344,300 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $8.7K | 2,145,300 | 0.0% |
| Tesaro Inc | COM | 881569107 | $7.9K | 95,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $7.7K | 205,000 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $7.2K | 225,000 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $7.1K | 511,469 | 0.0% |
| Visa Inc(V) | COM CL A | 92826C839 | $6.9K | 60,401 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $6.4K | 225,000 | 0.0% |
| Alphabet Inc(GOOGL) | CAP STK CL A | 02079K305 | $6.1K | 5,767 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $6.0K | 800,000 | 0.0% |
| Facebook Inc(META) | CL A | 30303M102 | $6.0K | 34,067 | 0.0% |
| Nomad Foods LTD(NOMD) | USD ORD SHS | G6564A105 | $5.8K | 340,162 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $5.7K | 119,779 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $5.5K | 325,000 | 0.0% |
| Obseva SA | COM | H5861P103 | $5.3K | 547,697 | 0.0% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $5.2K | 405,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $5.1K | 100,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $5.0K | 224,154 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $4.9K | 30,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $4.8K | 140,500 | 0.0% |